We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$119B
AUM Growth
-$2.4B
Cap. Flow
+$2.12B
Cap. Flow %
1.78%
Top 10 Hldgs %
24.78%
Holding
3,988
New
162
Increased
1,714
Reduced
1,756
Closed
200

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$99.6M
2
AAPL icon
Apple
AAPL
+$88.3M
3
MBB icon
iShares MBS ETF
MBB
+$85.4M
4
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$51.6M
5
CSCO icon
Cisco
CSCO
+$43.2M

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Financials 8.89%
3 Healthcare 8.4%
4 Industrials 6.56%
5 Consumer Discretionary 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDXG icon
3851
MiMedx Group
MDXG
$630M
-51,314
Closed -$339K
MDYG icon
3852
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
-3,175
Closed -$227K
MKTW icon
3853
MarketWise
MKTW
$52.8M
-849
Closed -$34K
MNRO icon
3854
Monro
MNRO
$365M
-17,691
Closed -$719K
ORIO
3855
Orion Digital Corp
ORIO
$18.7M
-3,603
Closed -$7.37K
MRVI icon
3856
Maravai LifeSciences
MRVI
$866M
-21,362
Closed -$266K
MTW icon
3857
Manitowoc
MTW
$702M
-118,638
Closed -$2.23M
NAK
3858
Northern Dynasty Minerals
NAK
$953M
-19,734
Closed -$4.74K
NEN icon
3859
New England Realty Associates
NEN
$195M
-3,000
Closed -$219K
NEO icon
3860
NeoGenomics
NEO
$2.12B
-11,189
Closed -$180K
NPO icon
3861
Enpro
NPO
$7.12B
-1,501
Closed -$200K
NUS icon
3862
Nu Skin
NUS
$236M
-9,675
Closed -$321K
NVCR icon
3863
NovoCure
NVCR
$2.06B
-8,250
Closed -$342K
NVS icon
3864
PUT
Novartis
NVS
$294B
-14,200
Closed -$1.31M
NVTS icon
3865
Navitas Semiconductor
NVTS
$3.55B
-56,475
Closed -$595K
OLPX
3866
DELISTED
Olaplex Holdings
OLPX
-54,696
Closed -$203K
OSUR icon
3867
OraSure Technologies
OSUR
$268M
-12,391
Closed -$62.1K
OTEX icon
3868
Open Text
OTEX
$5.81B
-5,096
Closed -$212K
OVID icon
3869
Ovid Therapeutics
OVID
$482M
-25,000
Closed -$82K
PDLB icon
3870
Ponce Financial Group
PDLB
$494M
-37,447
Closed -$325K
PEBO icon
3871
Peoples Bancorp
PEBO
$1.47B
-9,259
Closed -$246K
PFE icon
3872
CALL
Pfizer
PFE
$152B
-400
Closed -$16K
PFE icon
3873
PUT
Pfizer
PFE
$152B
-13,600
Closed -$544K
PHR icon
3874
Phreesia
PHR
$758M
-10,922
Closed -$339K
PKX icon
3875
POSCO
PKX
$17.3B
-5,794
Closed -$428K

Similar funds

Raymond James & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Raymond James & Associates held 3,988 positions worth $119B, down 2% from $121B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q3 2023 filing shows 162 new, 1,714 increased, 1,756 reduced and 200 closed positions. Its largest new stake was InterContinental Hotels: 102,555 shares worth $7.67M. The largest sale was RTX Corp, an estimated $99.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2023 buy was InterContinental Hotels: 102,555 shares worth $7.67M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q3 2023, an estimated $630M increase.
  • Raymond James & Associates's biggest Q3 2023 reduction was RTX Corp, cutting an estimated $99.6M.
  • Raymond James & Associates fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $17.3M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $119B portfolio in Q3 2023.
  • Raymond James & Associates opened 162 new positions and closed 200 in Q3 2023.
  • Raymond James & Associates's portfolio value fell 2% quarter-over-quarter to $119B.

Based on Raymond James & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.